Information for patients
Cancer Patients' and Caregivers' Perspectives on Biomarker Testing in Canada | Epidemiology, Biostatistics and Occupational Health - McGill University
FoundationOne Liquid CDx – P190032/S001 | FDA
Foundation Medicine receives FDA approval for pan-tumour biopsy test
Screening existing FDA-approved drugs leads to new treatments for pediatric cancer - Morgan Adams Foundation
Genetic Testing in Advanced Prostate Cancer - YouTube
GO2 Foundation for Lung Cancer
Genomics in Sarcoma discussion - Sarcoma Foundation of America
What Do I Need to Know About Genetic Testing for Colorectal Cancer? - Colon Cancer Foundation
FoundationOne Liquid CDx
Genetic Testing for Bladder Cancer - Urology Care Foundation
FoundationOne CDx | Leading Genomics Test NZ
Prostate cancer testing at Stamford Bridge - Chelsea Supporters' Trust
Unlocking the Power of Cancer Screening: Your Guide to Lifesaving Tests. - Medicaid Cancer Foundation
FoundationOne CDx | Foundation Medicine
Foundation Medicine | Communication Arts
Webinar: Hepatitis Prevention, Testing, and Treatment as Liver Cancer Prevention – Prevent Cancer Foundation
Understanding Biomarker Testing in Non-Small Cell Lung Cancer (NSCLC)
FoundationOne CDx
FDA Approves Foundation Medicine's FoundationOne CDx™, the First and Only Comprehensive Genomic Profiling Test for All Solid Tumors Incorporating Multiple Companion Diagnostics | Business Wire
